Report cover image

The U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments

Publisher BCC Research
Published Aug 25, 2026
Length 107 Pages
SKU # WA21553568

Description

Report Scope

This report examines the current and future market potential of the U.S. market for biodefense-related rapid pathogen identification and treatments. It offers a detailed analysis of the competitive environment, regulatory scenario, technological development, drivers and restraints, and identifies opportunities and trends in market growth.

The report provides an overview of the U.S. market for biodefense-related rapid pathogen identification and treatments and analyzes market trends. It includes global revenue ($ million) for the base year 2025 and estimated data for the forecast period 2026 to 2031. Based on type, the market is segmented into detection devices, sensors, and therapeutics. The detection devices segment is further segmented based on testing method and device type. The report also focuses on segmentation based on application and end user. The application segmentation includes detection and diagnosis, prevention, and treatment.

By end user, the market is segmented into academic and research institutes, government and defense agencies, hospitals, and pharma and biotechnology companies. The report focuses on the major emerging technologies that affect the market and vendor landscape. It also has a dedicated section of company profiles that covers details of leading key companies.

Report Includes
  • 28 data tables and 51 additional tables
  • An overview and analysis of the U.S. market for biodefense-related rapid pathogen identification and treatments
  • Analyses of market trends, with revenue data for 2023-2025, estimates for 2026, and forecasts through 2031
  • Market segmentation analysis by type, including detection devices and sensors
  • Market breakdown by application, including detection and diagnosis, prevention, and treatment
  • Market analysis by end user, including academic and research institutes, government and defense agencies, hospitals, and pharma and biotechnology companies
  • Facts and figures related to market dynamics, including key drivers, restraints, and opportunities
  • Insights derived from Porter’s Five Forces analysis
  • Discussion of emerging technologies, recent developments, and patent activity
  • Analysis of the competitive landscape, including industry structure and company share analysis
  • Company profiles of the leading players, including Thermo Fisher Scientific Inc., Biomerieux, F. Hoffmann-La Roche Ltd., Abbott, and OraSure Technologies Inc.


Companies Mentioned

Abbott
Agilent Technologies Inc.
Bd
Biomerieux
Bio-rad Laboratories Inc.
Cepheid
Charles River Laboratories
F. Hoffmann-la Roche Ltd.
Genscript
Gsk Plc
Illumina Inc.
Johnson & Johnson
Orasure Technologies Inc.
Qiagen
Revvity
Thermo Fisher Scientific Inc.

Table of Contents

107 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Conclusion
Chapter 2 Market Overview
Overview
Delivery and Detection
Methods of Dissemination
Rapid Identification Products
Treatment
Vaccines
Antibiotics
Antimicrobial Resistance
Porter’s Five Forces Analysis
Threat of New Entrants (Moderate)
Bargaining Power of Suppliers (Low to Moderate)
Bargaining Power of Buyers (High)
Threat of Substitute Products (Low)
Industry Rivalry (High)
Macroeconomic Factor Analysis
U.S. Tariffs
Increasing Healthcare Expenditures
Geopolitical Factors
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
High Federal Funding and Biodefense Investments
Increasing Need for Infectious Disease Detection and Outbreak Surveillance
Increased Emergency Use Authorizations and Product Approvals
Market Restraints
High Equipment and Testing Costs
Lack of Awareness and Underdiagnosis of Infectious Conditions
Regulatory Barriers
Market Opportunities
Pathogen-Agnostic Detection Approaches
Point-of-Care Testing
Self-Testing Kits for Pathogen Detection
Chapter 4 Regulatory Landscape
U.S. Regulatory Aspects of Pathogen Identification Devices
U.S. Regulatory Aspects of Therapeutics for Pathogenic Conditions
Chapter 5 Emerging Technologies
Key Takeaways
Emerging Technologies
Multiplex PCR Syndromic Testing
AI-Based Biodefense Surveillance
Messenger RNA (mRNA) Vaccines
CRISPR-Based Diagnostics
Lab-on-a-Chip Systems for Public Health Monitoring
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Type
Key Takeaways
Detection Devices
Sensors
Therapeutics
Market Analysis by Application
Key Takeaways
Detection and Diagnosis
Prevention
Treatment
Market Analysis by End User
Key Takeaways
Government and Defense Agencies
Hospitals
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Chapter 7 Competitive Intelligence
Key Takeaways
Industry Structure
Competitive Analysis of U.S. Market for Biodefense-Related Rapid Pathogen Identification and Treatments
Strategic Analysis
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
CEPHEID
CHARLES RIVER LABORATORIES
F. HOFFMANN-LA ROCHE LTD.
GENSCRIPT
GSK PLC
ILLUMINA INC.
JOHNSON & JOHNSON
ORASURE TECHNOLOGIES INC.
QIAGEN
REVVITY
THERMO FISHER SCIENTIFIC INC.
Emerging Startups/Market Disruptors

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us